Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
19th week of 2021 patent applcation highlights part 11
Patent application number
Title
Published
20210137994
FECAL MATTER FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES
2021-05-13
20210137995
MATERIAL DEPOSITING SYSTEM FOR TREATING A PATIENT
2021-05-13
20210137996
EDIBLE BIRD'S NEST EXTRACT AND METHOD OF EXTRACTION
2021-05-13
20210137997
COMPOSITIONS AND METHODS FOR PROMOTING SKIN HEALTH
2021-05-13
20210137998
HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
2021-05-13
20210137999
MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE
2021-05-13
20210138000
MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE
2021-05-13
20210138001
DIAGNOSIS, PREVENTION AND TREATMENT OF DEMYELINATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM
2021-05-13
20210138002
PREPARATION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE USING A WHOLE PLANT FIBRE EXTRACT FROM SUGARCANE
2021-05-13
20210138003
NOVEL STRAINS HAVING EFFECTS OF PREVENTING OR TREATING CANCERS
2021-05-13
20210138004
THERAPEUTIC USES OF LACTOBACILLUS PLANTARUM
2021-05-13
20210138005
NOVEL VIBRIO PARAHAEMOLYTICUS BACTERIOPHAGE VIB-PAP-7 AND USE OF SAME FOR INHIBITING VIBRIO PARAHAEMOLYTICUS BACTERIA PROLIFERATION
2021-05-13
20210138006
Systems, Methods, and Compositions for Treating or Preventing Bacterial Infection and for Reducing or Preventing Bacterial Overpopulation
2021-05-13
20210138007
ONCOLYTIC HSV VECTOR
2021-05-13
20210138008
RECOMBINANT ONCOLYTIC VIRUS COMPOSITION AND USE THEREOF
2021-05-13
20210138009
Recombinant Herpes Simplex Virus for Cancer Immunotherapy
2021-05-13
20210138010
WHOLE GINSENG COMPOSITION USING GINSENG ROOTS, LEAVES AND BERRIES AND METHOD OF PREPARING THE SAME
2021-05-13
20210138011
COMPOSITION FOR PREVENTING HAIR LOSS AND STIMULATING HAIR GROWTH
2021-05-13
20210138012
COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING RESPIRATORY DISEASE COMPRISING SIRAITIA GROSVENORII EXTRACT AS EFFECTIVE COMPONENT
2021-05-13
20210138013
COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF HAEMORRHOIDS
2021-05-13
20210138014
SYNERGISTIC HERBAL COMPOSITIONS FOR TESTOSTERONE BOOSTING
2021-05-13
20210138015
OLIVE DERIVED CELL CULTURE AND METHODS FOR PREPARING AND USING THE SAME
2021-05-13
20210138016
Novel Polygonum Cuspidatum Extracts and Their Use as Photodynamic Inactivating Agents
2021-05-13
20210138017
Kravinol
2021-05-13
20210138018
SKIN SENSITIZER DELIVERY SYSTEM
2021-05-13
20210138019
COMPOSITION COMPRISING YUZU SEED EXTRACT AND BROWN RICE EXTRACT
2021-05-13
20210138020
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
2021-05-13
20210138021
TREATMENT FOR ISCHEMIC STROKE
2021-05-13
20210138022
APPLICATION OF EARTHWORM PROTEIN PEPTIDE IN PREPARATION OF MEDICINE FOR PREVENTING AND/OR TREATING THROMBOTIC DISEASE
2021-05-13
20210138023
PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLAMMATORY CYTOKINES
2021-05-13
20210138024
MANUFACTURE OF DEGARELIX
2021-05-13
20210138025
CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES
2021-05-13
20210138026
METHOD OF TREATING OPHTHALMIC CONDITIONS
2021-05-13
20210138027
AQUEOUS SUSPENSIONS OF CYCLOSPORIN
2021-05-13
20210138028
TREATING OR PREVENTING ADVERSE LIVER CONDITIONS
2021-05-13
20210138029
POLYPEPTIDES FOR MANAGING VIRAL INFECTIONS
2021-05-13
20210138030
APPLICATION OF RYR2 PROTEIN OR RECOMBINANT RYR2 PROTEIN IN PREPARING ANTI-HEART FAILURE MEDICAMENT
2021-05-13
20210138031
COMPOSITIONS, METHODS AND KITS FOR TREATING COMPLEMENT RELATED DISORDERS
2021-05-13
20210138032
NON-ANTIBODY VEGF ANTAGONISTS FOR THE TREATMENT OF NEOVASCULAR GLAUCOMA
2021-05-13
20210138033
nNIF AND nNIF-RELATED PEPTIDES AND RELATED METHODS
2021-05-13
20210138034
TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES WITH APOLIPOPROTEIN MIMETICS
2021-05-13
20210138035
C3 FUSION PROTEIN AND METHODS OF MAKING AND USING THEREOF
2021-05-13
20210138036
Method for Treating or Preventing Radiotherapy-and Chemotherapy-Associated Oral Mucositis Using Locally Administered Heparin Binding Epidermal Growth Factor Like Growth Factor (HB-EGF)
2021-05-13
20210138037
NOVEL APPLICATION OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR FOR MEDICAL PURPOSES
2021-05-13
20210138038
METHODS OF USE FOR IL-22 IN THE TREATMENT OF GASTROINTESTINAL GRAFT VS. HOST DISEASE
2021-05-13
20210138039
PAIN RESPONSE MEDIATOR COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
2021-05-13
20210138040
METHOD OF TREATING DIABETES TYPE 2 BY ADMINISTERING ULTRARAPID ACTING INSULIN
2021-05-13
20210138041
Diketopiperazine salts for drug delivery and related methods
2021-05-13
20210138042
FORMULATIONS FOR NUTRITIONAL SUPPORT IN SUBJECTS IN NEED THEREOF
2021-05-13
20210138043
COMPOUNDS AND METHODS FOR THE IMMOBILIZATION OF MYOSTATIN-INHIBITORS ON THE EXTRACELLULAR MATRIX BY TRANSGLUTAMINASE
2021-05-13
20210138044
SOLUBLE BACTERIAL AND FUNGAL PROTEINS AND METHODS AND USES THEREOF IN INHIBITING AND DISPERSING BIOFILM
2021-05-13
20210138045
DOSAGE FORMS OF TISSUE KALLIKREIN 1
2021-05-13
20210138046
Methods and Compositions For Thrombolysis
2021-05-13
20210138047
KIDNEY INJURY TREATMENT
2021-05-13
20210138048
PEPTIDE VACCINES USABLE FOR HYPERCHOLESTEROLEMIA RELATED DISEASES
2021-05-13
20210138049
PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND FORMULATIONS THEREOF FOR TREATMENT OF SYNUCLEINOPATHIES
2021-05-13
20210138050
INTRACELLULAR DELIVERY OF BIOMOLECULES TO INDUCE TOLERANCE
2021-05-13
20210138051
Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased Cytotoxicity
2021-05-13
20210138052
A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS
2021-05-13
20210138053
ANTI-TUMORAL COMPOSITION
2021-05-13
20210138054
PEPTIDES DERIVED FROM PROSTATE SPECIFIC ANTIGEN (KLK3) AND COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES
2021-05-13
20210138055
COMPOSITIONS, METHODS AND USES FOR MODULATING THE TUMOR MICROENVIRONMENT TO ENHANCE ANTITUMOR IMMUNITY
2021-05-13
20210138056
NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
2021-05-13
20210138057
Anti-Microbial Immunomodulation
2021-05-13
20210138058
COMPOSITIONS
2021-05-13
20210138059
GLYCOCONJUGATE VACCINES COMPRISING BASIC UNITS OF A MOLECULAR CONSTRUCT EXPRESSING BUILT-IN MULTIPLE EPITOPES FOR THE FORMULATION OF A BROAD-SPECTRUM VACCINE AGAINST INFECTIONS DUE TO ENTEROPATHOGENIC BACTERIA
2021-05-13
20210138060
Protein Purification
2021-05-13
20210138061
Extreme Polyvalency Induces Potent Cross-Clade Cellular and Humoral Responses in Rabbits and Non-human Primates
2021-05-13
20210138062
COMPOSITIONS AND METHODS TO TREAT AIDS
2021-05-13
20210138063
HCV VACCINES
2021-05-13
20210138064
ANTIGEN-SURFACE-COUPLED LIPOSOME VACCINE FOR NON-HUMAN ANIMALS
2021-05-13
20210138065
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATE
2021-05-13
20210138066
REMOTE-CONTROLLED IMAGE-GUIDED DRUG DELIVERY VIA ULTRASOUND-MODULATED MOLECULAR DIFFUSION
2021-05-13
20210138067
COMBINATION THERAPY USING RILUZOLE TO ENHANCE TUMOR SENSITIVITY TO IONIZING RADIATION
2021-05-13
20210138068
PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN
2021-05-13
20210138069
TRIGLYCERIDE OTIC FORMULATIONS AND USES THEREOF
2021-05-13
20210138070
FORMULATION OF LONG-ACTING HUMAN GROWTH HORMONE IMMUNOGLOBULIN CONJUGATE
2021-05-13
20210138071
SILK-BASED PRODUCTS AND METHODS OF USE
2021-05-13
20210138072
COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS
2021-05-13
20210138073
OSTEOSTIMULATING ELASTOMERIC BONE FILLING COMPOSITIONS
2021-05-13
20210138074
POLYMER
2021-05-13
20210138075
CELL INTERNALIZING COMPOUNDS
2021-05-13
20210138076
CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
2021-05-13
20210138077
SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS
2021-05-13
20210138078
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
2021-05-13
20210138079
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
2021-05-13
20210138080
CONJUGATES
2021-05-13
20210138081
Amanitin Conjugates
2021-05-13
20210138082
TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY
2021-05-13
20210138083
ANTIBODY-DRUG CONJUCATES AND THEIR USES FOR THE TREATMENT OF CANCER
2021-05-13
20210138084
CONJUGATES OF ACTIVE PHARMACEUTICAL INGREDIENTS
2021-05-13
20210138085
A METHOD TO SYNTHESIZE A BIODEGRADABLE DEXTRAN FOR AGENT DELIVERY
2021-05-13
20210138086
ISOQUINOLINYL TRIAZOLONE COMPLEXES
2021-05-13
20210138087
METHOD FOR THE TREATMENT OF MALIGNANCIES
2021-05-13
20210138088
BISMUTH-IRON OXIDE CONTRAST AGENTS
2021-05-13
20210138089
NANOALLERGENS AND USES THEREOF
2021-05-13
20210138090
uPAR targeting peptide for use in peroperative optical imaging of invasive cancer
2021-05-13
20210138091
USES OF LABELED HSP90 INHIBITORS
2021-05-13
20210138092
SELECTIVE LIGANDS FOR TAU AGGREGATES
2021-05-13
20210138093
Radiotracer Derivatives Of Trimethoprim For Diagnostic Imaging
2021-05-13